- Home
- CLDI vs DUO Comparison
CLDI vs DUO Comparison
Compare CLDI & DUO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDI
- DUO
- Stock Information
- Founded
- CLDI 2014
- DUO 2011
- Country
- CLDI United States
- DUO China
- Employees
- CLDI N/A
- DUO N/A
- Industry
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- DUO Real Estate
- Sector
- CLDI Health Care
- DUO Finance
- Exchange
- CLDI Nasdaq
- DUO Nasdaq
- Market Cap
- CLDI 10.2M
- DUO 11.4M
- IPO Year
- CLDI N/A
- DUO 2019
- Fundamental
- Price
- CLDI $0.23
- DUO $2.18
- Analyst Decision
- CLDI Strong Buy
- DUO
- Analyst Count
- CLDI 1
- DUO 0
- Target Price
- CLDI $10.00
- DUO N/A
- AVG Volume (30 Days)
- CLDI 1.8M
- DUO 178.9K
- Earning Date
- CLDI 08-12-2025
- DUO 07-07-2025
- Dividend Yield
- CLDI N/A
- DUO N/A
- EPS Growth
- CLDI N/A
- DUO N/A
- EPS
- CLDI N/A
- DUO 7.57
- Revenue
- CLDI N/A
- DUO $46,458,330.00
- Revenue This Year
- CLDI N/A
- DUO N/A
- Revenue Next Year
- CLDI N/A
- DUO N/A
- P/E Ratio
- CLDI N/A
- DUO $0.30
- Revenue Growth
- CLDI N/A
- DUO 19.00
- 52 Week Low
- CLDI $0.20
- DUO $2.13
- 52 Week High
- CLDI $3.89
- DUO $74.72
- Technical
- Relative Strength Index (RSI)
- CLDI 21.13
- DUO 29.52
- Support Level
- CLDI $0.31
- DUO $2.33
- Resistance Level
- CLDI $0.33
- DUO $2.49
- Average True Range (ATR)
- CLDI 0.04
- DUO 0.23
- MACD
- CLDI -0.01
- DUO -0.00
- Stochastic Oscillator
- CLDI 14.83
- DUO 3.76
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.
About DUO Fangdd Network Group Ltd.
Fangdd Network Group Ltd is an investment holding company. It is engaged in the provision of real estate information services through its online platform which also offers integrated marketing services for individual customers, real estate developers, and agents in China. Its SaaS-based solutions help real estate agents to connect with essential business resources, including customers, property listings, capital, and transaction data. The company generates the majority of its revenue from Base commission from transactions in China.